Anticorps Recombinant de lapin anti-CCL11/Eotaxin

CCL11/Eotaxin Recombinant Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

FC (Intra)

Conjugaison

Non conjugué

CloneNo.

243012F8

N° de cat : 98464-1-RR

Synonymes

C-C motif chemokine 11, Ccl11, Eosinophil chemotactic protein, Eotaxin, Scya11



Applications testées

Résultats positifs en FC (Intra)Transfected HEK-293T cells,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98464-1-RR cible CCL11/Eotaxin dans les applications de FC (Intra) et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène CCL11/Eotaxin Protéine recombinante Eg2400
Nom complet chemokine (C-C motif) ligand 11
Masse moléculaire calculée11kd
Numéro d’acquisition GenBankNM_011330
Symbole du gène Ccl11
Identification du gène (NCBI) 20292
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

CCL11 also named Eotaxin-1, was initially discovered as an eosinophil-specific chemoattractant. CCL11 plays a central role in both allergic and non-allergic inflammatory reactions by recruiting immune cells such as eosinophils,basophils and Th2 lymphocytes. CCL11 binds to the chemokine receptors CCR2, CCR3 and CCR5, with highest affinity to CCR3. High levels of CCL11 have been described in several chronic inflammatory diseases, such as allergic rhinitis, atopic dermatitis, asthma, gastrointestinal disease and rheumatoid arthritis.

Protocole

Product Specific Protocols
FC protocol for CCL11/Eotaxin antibody 98464-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}